Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elementis PLC Board/Management Information 2024

Dec 24, 2024

4640_mang_2024-12-24_8521b49b-4141-4cc5-af84-a0fa94fef48c.html

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 1972R

Elementis PLC

24 December 2024

24 December 2024

Elementis plc

Directorate Change

Elementis plc (the "Company"), global specialty chemicals company, today announces the appointment of Christopher Mills as a Non-Executive Director with effect from 1 January 2025.

Mr Mills founded Harwood Capital Management in 2011, a successor to its former parent company JO Hambro Capital Management, which he co-founded in 1993 and of which he was formerly the Chief Investment Officer. He is currently the Chief Executive Officer and Investment Manager of North Atlantic Smaller Companies Investment Trust plc, a UK listed investment trust, and a Non-Executive Director of several companies including Assetco plc, MJ Gleeson plc, PRS REIT plc and Oryx International Growth Fund Limited.

Mr Mills has indicated that he will donate his director fees received from the Company to the Harwood Charitable Trust, which provides educational support, mainly for doctors in Africa.

As at the date of this announcement, funds managed by Harwood Capital Management and its affiliates own 22.5 million shares in the Company.

The Board shares the frustration of many shareholders with the Company's valuation, which it believes has not reflected the quality of the business and its assets for some time. Mr Mills will support the Board on completing existing initiatives, including the strategic review of Talc, and potentially new initiatives to narrow the gap between the share price and the Company's intrinsic value.

John O'Higgins, Chair of the Board of the Company, said:

"We welcome Christopher to the Board, and look forward to benefiting from his track record of helping contribute to long term shareholder value creation."

The following information is disclosed in accordance with UKLR 6.4.8R(1) in relation to Mr Mills:

Current directorships* Previous directorships in the past five years*
Assetco plc Augean plc
Bigblu Broadband plc Curtis Banks Group Limited
Catalyst Media Group plc Gabelli Value Plus+ Trust plc
EKF Diagnostics Holdings plc Goals Soccer Centres plc
Frenkel Topping Group plc Sunlink Health Systems Inc
MJ Gleeson Plc Ten Entertainment Group plc
North Atlantic Smaller Companies Investment Trust plc Trellus Health plc
Oryx International Growth Fund Limited Sureserve Group plc
Renalytix plc

The PRS REIT plc
Hipgnosis Songs Fund Limited

*other publicly quoted companies only

The Company confirms that there are no other matters requiring disclosure pursuant to UKLR 6.4.8R (1) to (6) in respect of Mr Mills's appointment.

Enquiries

Elementis:

Anna Lawrence, Group General Counsel & Company Secretary:  020 8148 5966

Eva Hatfield, Head of Investor Relations:  07553 340380

Teneo:

Olivia Peters:  020 7353 4200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAUOAARSBUUUUA